Optisure ICD Lead
Device
Abbott Laboratories
Total Payments
$288,889
Transactions
243
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $288,889 | 243 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $288,889 | 243 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Optisure Lead Post Approval Study | Abbott Laboratories | $246,448 | 2 |
| Human Use Condition Study-Fluoroscopic Evaluation of 3D Curvature of Implanted Right Ventricular Leads in Humans | Abbott Laboratories | $42,441 | 0 |
Ad
Manufacturing Companies
- Abbott Laboratories $288,889
Product Information
- Type Device
- Total Payments $288,889
- Total Doctors 2
- Transactions 243
About Optisure ICD Lead
Optisure ICD Lead is a device associated with $288,889 in payments to 2 healthcare providers, recorded across 243 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2020. In 2020, $288,889 was paid across 243 transactions to 2 doctors.
The most common payment nature for Optisure ICD Lead is "Unspecified" ($288,889, 100.0% of total).
Optisure ICD Lead is associated with 2 research studies, including "Optisure Lead Post Approval Study" ($246,448).